Skip to content

Improvement effect of test food on menopausal symptoms -A randomized, double blinded, placebo controlled, parallel group comparison study-

Improvement effect of test food on menopausal symptoms -A randomized, double blinded, placebo controlled, parallel group comparison study- - Improvement effect on menopausal symptoms

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000041614
Enrollment
150
Registered
2020-08-31
Start date
2020-08-31
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adult

Interventions

Ingestion of test food 1 for 8 weeks Ingestion of test food 2 for 8 weeks Ingestion of placebo for 8 weeks

Sponsors

FANCL Corporation
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Age: from 40 to 60 years old 2. Gender: Female 3. Menstruation: perimenopause (irregular menstruation in the last year) or postmenopause (less than 3 years from last menstruation) 4. Simplified Menopausal Index (SMI): 26 points or more 5.Hot flash: Daily hot flashes

Exclusion criteria

Exclusion criteria: 1. Subjects who have serious medical history 2. Subjects who have severe diabetes 3. Subjects who receive treatment and/or medicine, which affect to result of the study 4. Subjects who have mental illness 5. Subjects who have thyroid gland malfunction 6. Subjects who take medicine or health foods, supplement that may affect the results of this study 7. Subjects who have been taking hormone replacement therapy now or within 3 months from the start of the study 8. Subjects who are allergic to test food (soybean) 9. Subjects with irregular eating habits and sleep rhythms (eg, late-night workers) 10.Subjects who may develop seasonal allergies, such as hay fever, that may interfere with sleep and daily life during the test period 11. Subjects who intend to become pregnant or lactating. 12. Subjects who are planned to participate in other clinical study. 13. Subjects who are judged as unsuitable for the study by the investigator for other reason.

Design outcomes

Primary

MeasureTime frame
Simplified Menopausal Index(SMI), Severity and frequency of hot flash

Secondary

MeasureTime frame
POMS2-AS,AIS, unidentified complaints

Countries

Japan

Contacts

Public ContactAkiko Goto

Kenkoin Medical Corporation Foundation Kenkoin Clinic

akiko-goto@kenkoin.jp03-3573-1153

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026